<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Hysterectomy (benign indications): Patient-important issues and surgical complications
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Hysterectomy (benign indications): Patient-important issues and surgical complications
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Hysterectomy (benign indications): Patient-important issues and surgical complications
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Mark D Walters, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Cecile Ferrando, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Howard T Sharp, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kristen Eckler, MD, FACOG
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 08, 2024.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1344124308">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hysterectomy has evolved into multiple types of procedures, each with its own benefits and limitations. Beyond the traditional open abdominal approach (ie, laparotomy), hysterectomy can be performed vaginally or laparoscopically, and the development of robot-assisted systems has added variations to each. Selection of hysterectomy as a treatment is influenced by nonsurgical issues as well as potential operative complications.
        </p>
        <p>
         This topic review will discuss patient-reported nonsurgical outcomes and surgical complications associated with hysterectomy, regardless of approach. Topics on selection of a surgical route for hysterectomy and specific techniques are reviewed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3272.html" rel="external">
          "Hysterectomy (benign indications): Selection of surgical route"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3308.html" rel="external">
          "Hysterectomy: Vaginal"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3286.html" rel="external">
          "Hysterectomy: Laparoscopic"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3311.html" rel="external">
          "Hysterectomy: Abdominal (open) route"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/16554.html" rel="external">
          "Prophylactic vaginal apex suspension at the time of hysterectomy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         In this topic, when discussing study results, we will use the terms "woman/en" or "patient(s)" as they are used in the studies presented. We encourage the reader to consider the specific counseling and treatment needs of transgender and gender-diverse individuals.
        </p>
        <p class="headingAnchor" id="H2221004338">
         <span class="h1">
          HYSTERECTOMY INDICATIONS AND ALTERNATIVES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients are offered a hysterectomy in several scenarios, including:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         When medical or other therapeutic interventions fail to alleviate symptoms
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         There are no alternative effective therapies for their condition (eg, cancer)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Medical treatment is contraindicated
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         After informed counseling, the patient and surgeon choose surgical intervention over medical treatment
        </p>
        <p>
        </p>
        <p>
         Once the decision has been made to proceed with hysterectomy, the patient and physician select the surgical approach. The approach to selection in presented in related content. (See
         <a class="medical medical_review" href="/z/d/html/3272.html" rel="external">
          "Hysterectomy (benign indications): Selection of surgical route", section on 'Hysterectomy indications and alternatives'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4026331648">
         <span class="h1">
          PATIENT-REPORTED OUTCOMES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hysterectomy has been associated with improvements in physical and mental quality-of-life measures, body image, and aspects of sexual activity, with few differences reported among surgical routes [
         <a href="#rid1">
          1,2
         </a>
         ]. The nonsurgical outcomes of hysterectomy can be assessed in terms of symptom relief, psychosexual issues, and patient satisfaction.
        </p>
        <p class="headingAnchor" id="H3340480485">
         <span class="h2">
          Symptom relief
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hysterectomy generally improves the most common symptoms that lead to surgery, including problematic vaginal bleeding, pelvic or back pain, limitation of activity, sleep disturbance, fatigue, urinary incontinence, and vaginal bulging.
        </p>
        <p>
         Two studies from one prospective multicenter study of 1299 women who underwent hysterectomy reported [
         <a href="#rid3">
          3,4
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Substantial reduction of symptoms across these variables, and symptom reductions persisted at two years of follow-up  (
         <a class="graphic graphic_table graphicRef55870" href="/z/d/graphic/55870.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ninety-six percent of patients indicated the surgery had somewhat or completely resolved the symptoms for which they underwent surgery.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The individuals who had at least as many problematic symptoms after surgery as they did prior to surgery were more likely to have had low income or depression compared with women who reported symptom improvement.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         While bilateral oophorectomy was associated with lack of symptom relief at 24 months after surgery, lack of data regarding symptom type and treatments that may have been offered, such as hormone therapy for vasomotor symptoms, limit the utility of this study for educating patients. Discussions of bilateral oophorectomy and subsequent health outcomes are presented separately. (See
         <a class="medical medical_review" href="/z/d/html/14198.html" rel="external">
          "Elective oophorectomy or ovarian conservation at the time of hysterectomy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1490060364">
         <span class="h2">
          Psychosexual issues
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hysterectomy is unlikely to make sexual function or quality of life worse. Prospective studies have described positive effects on mood and quality of life. Studies on sexual function following hysterectomy, with or without oophorectomy, have reported neutral to positive outcomes, presumably because the symptoms that lead to the hysterectomy, such as abnormal uterine bleeding or pelvic pain, have resolved [
         <a href="#rid2">
          2,5-10
         </a>
         ]. These significant positive effects on postoperative sexual function and quality of life occur regardless of surgical technique used [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         While older studies reported adverse psychosocial outcomes from hysterectomy [
         <a href="#rid11">
          11,12
         </a>
         ], conclusions are limited by confounding factors [
         <a href="#rid12">
          12-14
         </a>
         ]. As above, newer data do not support this position.
        </p>
        <p class="headingAnchor" id="H3880176358">
         <span class="h2">
          Patient satisfaction
         </span>
         <span class="headingEndMark">
          —
         </span>
         A posthysterectomy survey in which US patients were asked whether the surgical procedure solved their prehysterectomy problems reported that 85 percent of women were completely satisfied, 11 percent mostly satisfied, 3 percent somewhat satisfied, and less than 1 percent were not satisfied [
         <a href="#rid4">
          4
         </a>
         ]. Overall, approximately 70 percent reported much better health after the surgery. However, among premenopausal patients, some regret at loss of fertility is common [
         <a href="#rid15">
          15
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1966383837">
         <span class="h2">
          Risk of occult malignancy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Despite appropriate preoperative assessment, occult uterine malignancy can be diagnosed at the time of hysterectomy for what was presumed to be benign disease.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Overall cancer incidence
         </strong>
         – Two retrospective reviews reported occult cancer rates of 0.19 to 0.82 for individuals undergoing hysterectomy for benign indications [
         <a href="#rid16">
          16,17
         </a>
         ]. Detailed discussion of occult malignancy, particularly sarcoma, in patients undergoing fibroid surgery is presented separately. (See
         <a class="medical medical_review" href="/z/d/html/14203.html" rel="external">
          "Uterine fibroids (leiomyomas): Differentiating fibroids from uterine sarcomas"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Types of gynecologic cancer
         </strong>
         – In the biggest study to date, a secondary analysis of the 2014-2015 American College of Surgeons National Surgical Quality Improvement Program dataset that included over 24,000 women undergoing benign hysterectomy, 1.4 percent of women had uterine cancer (ie, cancer of the uterine corpus), 0.60 percent had cervical cancer, and 0.19 percent had ovarian cancer [
         <a href="#rid18">
          18
         </a>
         ]. Additionally, prevalence rates of uterine cancer varied by surgical route, from a low of 0.23 percent for laparoscopic supracervical hysterectomy to a high of 1.89 percent for total laparoscopic or laparoscopic-assisted vaginal hysterectomy. This variation in cancer rate by procedure may reflect differences in the underlying surgical indications, differential patient selection by surgeons, or other factors. In the study, the majority of uterine and ovarian cancers were stage I (uterine, 80 percent and ovarian, 61 percent [
         <a href="#rid18">
          18
         </a>
         ]).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Impact of hysterectomy indication
         </strong>
         – The surgical indication for hysterectomy impacts the relative risk of occult malignancy. Hysterectomy for pelvic organ prolapse (POP) repair is at the lower end of the risk spectrum while prophylactic hysterectomy for cancer syndromes is at the higher end.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Pelvic organ prolapse repair
         </strong>
         – A meta-analysis of patients undergoing hysterectomy for POP repair reported a pooled prevalence of occult uterine malignancy of 0.22 percent (95% CI 0.11-0.35, 8 studies, 35,880 patients) [
         <a href="#rid19">
          19
         </a>
         ]. A different study of patients who underwent sacrocolpopexy with hysterectomy reported no uterine cancers (0 cancers in 238 patients) [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Hysterectomy for all benign indications
         </strong>
         – A retrospective cohort study of patients undergoing vaginal hysterectomy for benign indications reported an occult malignancy rate of 0.82 percent [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Prophylactic hysterectomy for cancer syndromes
         </strong>
         – Patients undergoing presumed benign prophylactic hysterectomy for cancer syndromes have increased rates of occult malignancy. In a study of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer), 13 percent (3 cancers in 23 patients) were diagnosed with occult endometrial cancer [
         <a href="#rid21">
          21
         </a>
         ]. In a study of 413 individuals undergoing prophylactic hysterectomy for multiple types of hereditary cancer syndromes, 4.6 percent were diagnosed with malignancy or premalignancy [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Age as a risk factor
         </strong>
         – In multivariate regression analysis, age ≥55 years, compared with age 40 to 54 years, was associated with a more than sixfold increased risk of uterine cancer, more than a threefold increased risk of ovarian cancer, and nearly twice the risk of cervical cancer [
         <a href="#rid18">
          18
         </a>
         ]. We find these data helpful in counseling our patients, particularly women age 55 and older.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Abnormal uterine bleeding
         </strong>
         – The evaluation of females with abnormal uterine bleeding, a common risk factor for uterus malignancy, is reviewed elsewhere.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3263.html" rel="external">
          "Abnormal uterine bleeding in nonpregnant reproductive-age patients: Terminology, evaluation, and approach to diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5476.html" rel="external">
          "Abnormal uterine bleeding in nonpregnant reproductive-age patients: Management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1070549140">
         <span class="h2">
          Decreased ovarian function or earlier menopause
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hysterectomy appears to reduce ovarian function and result in earlier onset of menopause despite ovarian conservation [
         <a href="#rid23">
          23-27
         </a>
         ]. While the studies below demonstrate reduced ovarian function after hysterectomy, it is not clear how much of the decreased ovarian activity is directly attributable to the surgery versus the underlying disease process for which the surgery was indicated. One potential explanation for decreased ovarian output after hysterectomy is alteration of the ovarian blood supply, even if the ovaries are retained [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Elevated follicle-stimulating hormone (FSH)
         </strong>
         – Removal of the uterus, without concomitant oophorectomy, appears to reduce ovarian reserve and cause earlier cessation of ovarian function.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Reduced ovarian function
         </strong>
         – In a prospective cohort study including over 850 women, women who underwent hysterectomy had nearly twice the risk of reduced ovarian function (defined as FSH ≥40 international units/L) compared with women with intact uteri [
         <a href="#rid26">
          26
         </a>
         ]. While the risk of decreased ovarian function was greater for women who had one ovary removed (adjusted hazard ratio [HR] 2.9) than for women who retained both ovaries (HR 1.7), both groups had significantly reduced ovarian function.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Earlier menopause
         </strong>
         – In a prospective study of over 500 women who were followed for five years, women who underwent hysterectomy reached menopause, defined as FSH ≥40 international units/L, nearly four years earlier than control women who did not undergo hysterectomy [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Decreased anti-müllerian hormone (AMH)
         </strong>
         – In a planned secondary analysis of the above study that measured anti-müllerian hormone (AMH) levels one year after hysterectomy, women who had undergone hysterectomy had a 23 percent reduction in overall AMH levels, a greater median percentage decrease in AMH levels, and a higher proportion of women with undetectable AMH compared with control women who did not undergo hysterectomy, despite both groups having similar baseline AMH levels [
         <a href="#rid27">
          27
         </a>
         ]. This study suggests that the ovarian damage associated with hysterectomy is unrelated to baseline ovarian reserve.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3253760578">
         <span class="h2">
          Cardiovascular and metabolic morbidity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Large observational studies have reported hysterectomy is associated with a small but significant increased risk of cardiovascular morbidity, independent of oophorectomy [
         <a href="#rid29">
          29-35
         </a>
         ]. In a 2017 cohort study with a median of 21.9 years of follow-up, when compared with matched women who did not undergo hysterectomy, women who underwent hysterectomy with ovarian conservation had slightly increased risks of de novo hyperlipidemia (HR 1.14, 95% CI 1.05-1.25), hypertension (HR 1.13, 95% CI 1.03-1.25), obesity (HR 1.18, 95% CI 1.04-1.35), cardiac arrhythmia (HR 1.17, 95% CI 1.05-1.32), and coronary artery disease (HR 1.33, 95% CI 1.12-1.58) [
         <a href="#rid32">
          32
         </a>
         ]. These effects were particularly pronounced for women who underwent hysterectomy at age ≤35 years, as these women had a 2.5-fold increased risk of coronary artery disease and a 4.6-fold increased risk of congestive heart failure compared with reference women. It is biologically plausible that small changes in cardiovascular risk factors could have a cumulative impact over time and result in greater risk for women who undergo hysterectomy at younger ages.
        </p>
        <p>
         It is not known if the association between hysterectomy without oophorectomy and cardiovascular disease is causal, and if so, the mechanism(s) by which these changes may occur. Prior studies have documented altered ovarian function (eg, decreased levels of AMH) after ovary-sparing hysterectomy, which may be a contributing factor. In addition, the cardiovascular impact of the underlying disease that resulted in hysterectomy is not understood, as the risk for cardiovascular and metabolic outcomes differed by surgical indication in the above cohort study [
         <a href="#rid32">
          32
         </a>
         ]. (See
         <a class="local">
          'Decreased ovarian function or earlier menopause'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H4075520884">
         <span class="h2">
          Osteoporosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Studies have reported an increased risk of osteoporosis following hysterectomy, regardless of ovarian conservation or removal [
         <a href="#rid36">
          36,37
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2046.html" rel="external">
          "Screening for osteoporosis in postmenopausal women and men"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3712666759">
         <span class="h2">
          All-cause mortality
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bilateral oophorectomy, but not hysterectomy alone, appears to increase the risk of all-cause mortality when performed in younger individuals [
         <a href="#rid38">
          38
         </a>
         ]. A detailed discussion is presented elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/14198.html" rel="external">
          "Elective oophorectomy or ovarian conservation at the time of hysterectomy", section on 'All-cause mortality'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1873956711">
         <span class="h1">
          SURGICAL COMPLICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         General complications of hysterectomy are discussed here. Procedure-specific complications are discussed separately in the topic reviews on each type of hysterectomy.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3308.html" rel="external">
          "Hysterectomy: Vaginal"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3286.html" rel="external">
          "Hysterectomy: Laparoscopic"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3311.html" rel="external">
          "Hysterectomy: Abdominal (open) route"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H446826709">
         <span class="h2">
          Overall
         </span>
         <span class="headingEndMark">
          —
         </span>
         In an Australian population-based study of almost 80,000 hysterectomies performed for benign indications, complications were reported at the following rates [
         <a href="#rid39">
          39
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hemorrhage – 2.4 percent (see
         <a class="medical medical_review" href="/z/d/html/3302.html" rel="external">
          "Management of hemorrhage in gynecologic surgery"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Genitourinary disorders (eg, pelvic organ prolapse [POP], urinary retention, renal or ureteral injury) – 1.9 percent (see
         <a class="medical medical_review" href="/z/d/html/3289.html" rel="external">
          "Complications of gynecologic surgery"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Urinary tract infection – 1.6 percent (see
         <a class="medical medical_review" href="/z/d/html/8063.html" rel="external">
          "Acute simple cystitis in adult and adolescent females"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other infections – 1.6 percent (see
         <a class="medical medical_review" href="/z/d/html/2886.html" rel="external">
          "Fever in the surgical patient"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H421465000">
         <span class="h2">
          Urinary tract injury
         </span>
         <span class="headingEndMark">
          —
         </span>
         In a systematic review and meta-analysis of 79 studies of benign gynecologic surgeries, the rates of intra- and postoperative urinary tract injury per 1000 hysterectomies in which cystoscopy was not routinely used ranged from &lt;1 to 4 percent for ureteral injury and 5 to 17 percent for bladder injury [
         <a href="#rid40">
          40
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Abdominal approach
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Ureteral injury: 2.6
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Bladder injury: 5.8
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Vaginal approach
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Ureteral injury: 0.4
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Bladder injury: 5.1
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Laparoscopic approach
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Ureteral injury: 3.1
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Bladder injury: 7.3
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Robot-assisted approach
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Ureteral injury: 4.1
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Bladder injury: 16.5
        </p>
        <p>
        </p>
        <p>
         Data for laparoscopic hysterectomy included both laparoscopic-assisted vaginal and total laparoscopic hysterectomy. Several studies suggest that the incidence of urinary tract injury, and major complications in general, during laparoscopic hysterectomy is decreasing with time, which may reflect improved technology and increased surgical experience [
         <a href="#rid41">
          41,42
         </a>
         ]. Some of the variation in the injury rate range is due to the underlying pathology, degree of anatomic abnormality, surgeon experience, and sample size (particularly for robot-assisted laparoscopic hysterectomy).
        </p>
        <p>
         Adnexal surgery at the time of hysterectomy does not significantly increase the prevalence of urinary tract injury. In a retrospective study of a national database, urinary tract injury occurred in approximately 3 per 1000 hysterectomies that included adnexal surgery (route of hysterectomy not specified) [
         <a href="#rid43">
          43
         </a>
         ]. When adnexal surgery was performed alone, the prevalence of urinary tract injury was lower at 1 per 1000 surgeries.
        </p>
        <p class="headingAnchor" id="H2155485146">
         <span class="h2">
          Urinary incontinence
         </span>
         <span class="headingEndMark">
          —
         </span>
         Studies have reported a variable impact of hysterectomy on urinary incontinence [
         <a href="#rid44">
          44-46
         </a>
         ]. Until definitive data are available, we counsel patients that hysterectomy may increase the risk of urinary incontinence over time. However, it is not clear if the surgery itself or other preoperative factors determine the likelihood of posthysterectomy urinary incontinence. Potential study confounders include the presence of baseline urinary symptoms and other pelvic floor disorders, different study methodologies, multiple indications for the hysterectomy, different surgical techniques, and varied length of follow-up.
        </p>
        <p>
         As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Increased urinary incontinence risk
         </strong>
         – Three large retrospective cohort studies reported hysterectomy was associated with increased risk of subsequent surgery for stress incontinence [
         <a href="#rid46">
          46,47
         </a>
         ] and increased incidence of both urge urinary incontinence and stress urinary incontinence [
         <a href="#rid48">
          48
         </a>
         ] compared with women who had not undergone hysterectomy.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mixed risk of urinary incontinence
         </strong>
         – In a retrospective cohort study of over 16,000 women who underwent hysterectomy and were followed for one year, 8.5 percent reported de novo urinary incontinence, 13.3 percent reported remission of prior urinary incontinence, and 16.1 percent reported continued urinary incontinence [
         <a href="#rid49">
          49
         </a>
         ]. Obesity (body mass index [BMI] ≥30 kg/m
         <sup>
          2
         </sup>
         ), prior vaginal delivery, and preoperative daily urinary urgency without incontinence were associated with increased risk of de novo posthysterectomy urinary incontinence while BMI &lt;25 kg/m
         <sup>
          2
         </sup>
         , prolapse, fibroids, or lack of daily urge without incontinence were associated with remission of urinary incontinence symptoms.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          No difference in risk
         </strong>
         – Lastly, a small longitudinal cohort study that followed 661 women for 10 years reported no difference in incidence proportions of stress and urgency incontinence among women who underwent hysterectomy and women in the control groups (laparoscopic cholecystectomy and transcervical endometrial resection) [
         <a href="#rid50">
          50
         </a>
         ]. In all groups, the prevalence of stress and urgency urinary incontinence increased with time, and women in all three groups changed their status from continent to incontinent and vice versa. While this study group was much smaller than the others, the study provides 10-year prospective data.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2995596196">
         <span class="h2">
          Risk of pelvic organ prolapse
         </span>
         <span class="headingEndMark">
          —
         </span>
         Studies have reported mixed results on the role of hysterectomy in the development of subsequent pelvic organ prolapse (POP) [
         <a href="#rid51">
          51-62
         </a>
         ]. This discordancy likely reflects differences in patient populations (ie, proportion of patients with preexisting prolapse, age, menopausal status), surgical technique (ie, type of cuff closure and incorporation of support ligaments), lack of standardized outcome criteria, and differing lengths of follow-up. The controversy surrounding the impact of hysterectomy on subsequent prolapse and discussion of the role of apical repair to prevent prolapse are presented in detail in related content.
        </p>
        <p>
         Briefly, examples of the conflicting data include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Earlier cohort and case control studies generally reported the risk of future prolapse was highest when hysterectomy was performed in women with existing prolapse [
         <a href="#rid58">
          58-61
         </a>
         ], while the risk in women with normal pelvic support was less clear.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A 2018 retrospective cohort study including over 42,000 individuals who underwent hysterectomy with the index prolapse repair reported hysterectomy at the time of initial POP surgery reduced the risk of future POP surgery by approximately 30 percent [
         <a href="#rid62">
          62
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a 2020 observational study of 406 individuals that compared laparoscopic and vaginal hysterectomy, 17 percent overall were treated for subsequent POP; similar rates of prolapse occurrence were reported between the laparoscopic and vaginal nonprolapse groups (apical vault prolapse 4.4 versus 5.8 percent) [
         <a href="#rid63">
          63
         </a>
         ]. Prolapse after vaginal hysterectomy was more common in individuals whose surgical indication was prolapse (apical vault prolapse 23 percent).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1442101462">
         <span class="h2">
          Pelvic organ fistula
         </span>
         <span class="headingEndMark">
          —
         </span>
         In resource-rich countries, pelvic surgery such as hysterectomy is the most common cause of lower urinary tract fistula development. A case-control study of over 180,000 women reported a fourfold higher rate of subsequent surgery to repair a pelvic organ fistula in women who had undergone hysterectomy than in the control group [
         <a href="#rid64">
          64
         </a>
         ]. This differs from resource-limited countries in which pelvic organ fistulas are most commonly related to obstetric injury.
        </p>
        <p class="headingAnchor" id="H3926891264">
         <span class="h2">
          Vaginal cuff dehiscence
         </span>
         <span class="headingEndMark">
          —
         </span>
         Vaginal cuff dehiscence, or separation of the previously closed vaginal cuff, can occur following hysterectomy by any route. Robot-assisted hysterectomy appears to be associated with the highest risk. Risk factors, diagnosis, and management of vaginal cuff dehiscence are presented elsewhere.
        </p>
        <p class="headingAnchor" id="H210541339">
         <span class="h2">
          Persistent opioid use
         </span>
         <span class="headingEndMark">
          —
         </span>
         Approximately 5 percent of patients report continued opioid use after benign hysterectomy, although the rates vary with the study population and definition used [
         <a href="#rid65">
          65,66
         </a>
         ]. A meta-analysis including over 370,000 patients undergoing hysterectomy for benign indications reported risk factors for continued opioid use included younger age, smoking history, alcohol use, back pain, and fibromyalgia [
         <a href="#rid65">
          65
         </a>
         ]. The route of hysterectomy did not impact risk. (See
         <a class="medical medical_review" href="/z/d/html/134254.html" rel="external">
          "Use of opioids for postoperative pain control"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2806346207">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Patient important outcomes
         </strong>
         – Hysterectomy has been associated with improvements in physical and mental quality-of-life measures, body image, and aspects of sexual activity, with few differences reported among surgical routes. (See
         <a class="local">
          'Patient-reported outcomes'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Symptom relief
         </strong>
         – Hysterectomy generally improves the most common symptoms that lead to surgery, including problematic vaginal bleeding, pelvic or back pain, limitation of activity, sleep disturbance, fatigue, urinary incontinence, and vaginal bulging. (See
         <a class="local">
          'Symptom relief'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Psychosexual function
         </strong>
         – Hysterectomy is unlikely to make sexual function or quality of life worse. Studies on sexual function following hysterectomy have reported neutral to positive outcomes, presumably because the symptoms that lead to the hysterectomy have resolved. (See
         <a class="local">
          'Psychosexual issues'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Patient satisfaction
         </strong>
         – The vast majority of patients who elect hysterectomy report satisfaction with the improvement in their preoperative symptoms. However, some regret at loss of fertility is common. (See
         <a class="local">
          'Patient satisfaction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Risk of occult malignancy
         </strong>
         – Despite appropriate preoperative assessment, occult uterine malignancy can be diagnosed at the time of hysterectomy for what was presumed to be benign disease. Risk of occult cancer varies based on the type of malignancy and indications for surgery. (See
         <a class="local">
          'Risk of occult malignancy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Decreased ovarian function and earlier menopause
         </strong>
         – Hysterectomy appears to reduce ovarian function and result in earlier onset of menopause even with ovary conservation. It is not known how much of the decreased ovarian activity is directly attributable to the surgery versus the underlying disease process for which the surgery was indicated. (See
         <a class="local">
          'Decreased ovarian function or earlier menopause'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Cardiovascular and metabolic morbidity
         </strong>
         – Studies have reported hysterectomy is associated with a small but significant increased risk of cardiovascular morbidity, independent of oophorectomy. It is not known if the association between hysterectomy without oophorectomy and cardiovascular disease is causal, and if so, the mechanism(s) by which these changes may occur. (See
         <a class="local">
          'Cardiovascular and metabolic morbidity'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Surgical complications
         </strong>
         – In addition to routine surgical complications, hysterectomy may contribute to the development of urinary incontinence and pelvic organ prolapse (POP). (See
         <a class="local">
          'Surgical complications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Urinary incontinence
         </strong>
         – Studies have reported a variable impact of hysterectomy on urinary incontinence. Until definitive data are available, we counsel patients that hysterectomy may increase the risk of urinary incontinence over time. (See
         <a class="local">
          'Urinary incontinence'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Pelvic organ prolapse (POP)
         </strong>
         – Studies have reported mixed results on the role of hysterectomy in the development of subsequent POP. The risk of subsequent prolapse is greatest for patients who have underlying prolapse as the indication for the hysterectomy. (See
         <a class="local">
          'Risk of pelvic organ prolapse'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Garry R, Fountain J, Mason S, et al. The eVALuate study: two parallel randomised trials, one comparing laparoscopic with abdominal hysterectomy, the other comparing laparoscopic with vaginal hysterectomy. BMJ 2004; 328:129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Radosa JC, Meyberg-Solomayer G, Kastl C, et al. Influences of different hysterectomy techniques on patients' postoperative sexual function and quality of life. J Sex Med 2014; 11:2342.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kjerulff KH, Langenberg PW, Rhodes JC, et al. Effectiveness of hysterectomy. Obstet Gynecol 2000; 95:319.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kjerulff KH, Rhodes JC, Langenberg PW, Harvey LA. Patient satisfaction with results of hysterectomy. Am J Obstet Gynecol 2000; 183:1440.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roovers JP, van der Bom JG, van der Vaart CH, Heintz AP. Hysterectomy and sexual wellbeing: prospective observational study of vaginal hysterectomy, subtotal abdominal hysterectomy, and total abdominal hysterectomy. BMJ 2003; 327:774.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rhodes JC, Kjerulff KH, Langenberg PW, Guzinski GM. Hysterectomy and sexual functioning. JAMA 1999; 282:1934.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aziz A, Brännström M, Bergquist C, Silfverstolpe G. Perimenopausal androgen decline after oophorectomy does not influence sexuality or psychological well-being. Fertil Steril 2005; 83:1021.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carlson KJ, Miller BA, Fowler FJ Jr. The Maine Women's Health Study: I. Outcomes of hysterectomy. Obstet Gynecol 1994; 83:556.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brito LG, Pouwels NS, Einarsson JI. Sexual function after hysterectomy and myomectomy. Surg Technol Int 2014; 25:191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Humalajärvi N, Aukee P, Kairaluoma MV, et al. Quality of life and pelvic floor dysfunction symptoms after hysterectomy with or without pelvic organ prolapse. Eur J Obstet Gynecol Reprod Biol 2014; 182:16.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khastgir G, Studd JW, Catalan J. The psychological outcome of hysterectomy. Gynecol Endocrinol 2000; 14:132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khastgir G, Studd J. Hysterectomy, ovarian failure, and depression. Menopause 1998; 5:113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farrell SA, Kieser K. Sexuality after hysterectomy. Obstet Gynecol 2000; 95:1045.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           MENZER D, MORRIS T, GATES P, et al. Patterns of emotional recovery from hysterectomy; first in a series of reports. Psychosom Med 1957; 19:379.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farquhar CM, Harvey SA, Yu Y, et al. A prospective study of 3 years of outcomes after hysterectomy with and without oophorectomy. Am J Obstet Gynecol 2006; 194:711.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parsons LHP, Pedersen R, Richardson DL, Kho KA. The prevalence of occult endometrial cancer in women undergoing hysterectomy for benign indications. Eur J Obstet Gynecol Reprod Biol 2018; 223:108.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wasson M, Magtibay P 2nd, Magtibay P 3rd, Magrina J. Incidence of Occult Uterine Malignancy Following Vaginal Hysterectomy With Morcellation. J Minim Invasive Gynecol 2017; 24:665.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Desai VB, Wright JD, Schwartz PE, et al. Occult Gynecologic Cancer in Women Undergoing Hysterectomy or Myomectomy for Benign Indications. Obstet Gynecol 2018; 131:642.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Davenport E, James L, Parks T, Howard DL. Occult Uterine Malignancy at the Time of Surgery for Pelvic Organ Prolapse: A Systematic Review and Meta-analysis. Female Pelvic Med Reconstr Surg 2021; 27:e282.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang OH, Ferrando CA. Occult Uterine Malignancy at the Time of Sacrocolpopexy in the Context of the Safety Communication on Power Morcellation by the FDA. J Minim Invasive Gynecol 2021; 28:788.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lachiewicz MP, Kravochuck SE, O'Malley MM, et al. Prevalence of occult gynecologic malignancy at the time of risk reducing and nonprophylactic surgery in patients with Lynch syndrome. Gynecol Oncol 2014; 132:434.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wong S, Ratner E, Buza N. Intra-operative evaluation of prophylactic hysterectomy and salpingo-oophorectomy specimens in hereditary gynaecological cancer syndromes. Histopathology 2018; 73:109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Halmesmäki K, Hurskainen R, Tiitinen A, et al. A randomized controlled trial of hysterectomy or levonorgestrel-releasing intrauterine system in the treatment of menorrhagia-effect on FSH levels and menopausal symptoms. Hum Reprod 2004; 19:378.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farquhar CM, Sadler L, Harvey SA, Stewart AW. The association of hysterectomy and menopause: a prospective cohort study. BJOG 2005; 112:956.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ahn EH, Bai SW, Song CH, et al. Effect of hysterectomy on conserved ovarian function. Yonsei Med J 2002; 43:53.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moorman PG, Myers ER, Schildkraut JM, et al. Effect of hysterectomy with ovarian preservation on ovarian function. Obstet Gynecol 2011; 118:1271.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trabuco EC, Moorman PG, Algeciras-Schimnich A, et al. Association of Ovary-Sparing Hysterectomy With Ovarian Reserve. Obstet Gynecol 2016; 127:819.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singha A, Saha S, Bhattacharjee R, et al. DETERIORARON OF OVARIAN FUNCTION AFTER TOTAL ABDOMINAL HYSTERECTOMY WITH PRESERVARON OF OVARIES. Endocr Pract 2016; 22:1387.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ingelsson E, Lundholm C, Johansson AL, Altman D. Hysterectomy and risk of cardiovascular disease: a population-based cohort study. Eur Heart J 2011; 32:745.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yeh JS, Cheng HM, Hsu PF, et al. Hysterectomy in young women associates with higher risk of stroke: a nationwide cohort study. Int J Cardiol 2013; 168:2616.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gierach GL, Pfeiffer RM, Patel DA, et al. Long-term overall and disease-specific mortality associated with benign gynecologic surgery performed at different ages. Menopause 2014; 21:592.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laughlin-Tommaso SK, Khan Z, Weaver AL, et al. Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study. Menopause 2018; 25:483.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang Z, Li X, Zhang D. Impact of hysterectomy on cardiovascular disease and different subtypes: a meta-analysis. Arch Gynecol Obstet 2022; 305:1255.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yuk JS, Kim BG, Lee BK, et al. Association of Early Hysterectomy With Risk of Cardiovascular Disease in Korean Women. JAMA Netw Open 2023; 6:e2317145.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen IJ, Shoupe D, Karim R, et al. The association of hysterectomy with or without ovarian conservation with subclinical atherosclerosis progression in healthy postmenopausal women. Menopause 2023; 30:692.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Choi HG, Jung YJ, Lee SW. Increased risk of osteoporosis with hysterectomy: A longitudinal follow-up study using a national sample cohort. Am J Obstet Gynecol 2019; 220:573.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seo YS, Yuk JS. Osteoporosis and Fracture Risk Following Benign Hysterectomy Among Female Patients in Korea. JAMA Netw Open 2023; 6:e2347323.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cusimano MC, Chiu M, Ferguson SE, et al. Association of bilateral salpingo-oophorectomy with all cause and cause specific mortality: population based cohort study. BMJ 2021; 375:e067528.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spilsbury K, Hammond I, Bulsara M, Semmens JB. Morbidity outcomes of 78,577 hysterectomies for benign reasons over 23 years. BJOG 2008; 115:1473.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Teeluckdharry B, Gilmour D, Flowerdew G. Urinary Tract Injury at Benign Gynecologic Surgery and the Role of Cystoscopy: A Systematic Review and Meta-analysis. Obstet Gynecol 2015; 126:1161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mäkinen J, Brummer T, Jalkanen J, et al. Ten years of progress--improved hysterectomy outcomes in Finland 1996-2006: a longitudinal observation study. BMJ Open 2013; 3:e003169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Settnes A, Moeller C, Topsoee MF, et al. Complications after benign hysterectomy, according to procedure: a population-based prospective cohort study from the Danish hysterectomy database, 2004-2015. BJOG 2020; 127:1269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gilmour DT, Baskett TF. Disability and litigation from urinary tract injuries at benign gynecologic surgery in Canada. Obstet Gynecol 2005; 105:109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van der Vaart CH, van der Bom JG, de Leeuw JR, et al. The contribution of hysterectomy to the occurrence of urge and stress urinary incontinence symptoms. BJOG 2002; 109:149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brown JS, Sawaya G, Thom DH, Grady D. Hysterectomy and urinary incontinence: a systematic review. Lancet 2000; 356:535.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Altman D, Granath F, Cnattingius S, Falconer C. Hysterectomy and risk of stress-urinary-incontinence surgery: nationwide cohort study. Lancet 2007; 370:1494.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Christoffersen NM, Klarskov N, Gradel KO, Husby KR. Increased risk of stress urinary incontinence surgery after hysterectomy for benign indication-a population-based cohort study. Am J Obstet Gynecol 2023; 229:149.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kudish BI, Shveiky D, Gutman RE, et al. Hysterectomy and urinary incontinence in postmenopausal women. Int Urogynecol J 2014; 25:1523.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bohlin KS, Ankardal M, Lindkvist H, Milsom I. Factors influencing the incidence and remission of urinary incontinence after hysterectomy. Am J Obstet Gynecol 2017; 216:53.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Christiansen UJ, Hansen MJ, Lauszus FF. Hysterectomy is not associated with de-novo urinary incontinence: A ten-year cohort study. Eur J Obstet Gynecol Reprod Biol 2017; 215:175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Altman D, Falconer C, Cnattingius S, Granath F. Pelvic organ prolapse surgery following hysterectomy on benign indications. Am J Obstet Gynecol 2008; 198:572.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aigmueller T, Dungl A, Hinterholzer S, et al. An estimation of the frequency of surgery for posthysterectomy vault prolapse. Int Urogynecol J 2010; 21:299.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           ACOG Committee on Practice Bulletins--Gynecology. ACOG Practice Bulletin No. 85: Pelvic organ prolapse. Obstet Gynecol 2007; 110:717.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           AAGL Advancing Minimally Invasive Gynecology Worldwide. AAGL practice report: Practice Guidelines on the Prevention of Apical Prolapse at the Time of Benign Hysterectomy. J Minim Invasive Gynecol 2014; 21:715.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olsen AL, Smith VJ, Bergstrom JO, et al. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 1997; 89:501.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hendrix SL, Clark A, Nygaard I, et al. Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity. Am J Obstet Gynecol 2002; 186:1160.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hendrix SL, Cochrane BB, Nygaard IE, et al. Effects of estrogen with and without progestin on urinary incontinence. JAMA 2005; 293:935.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dällenbach P, Kaelin-Gambirasio I, Dubuisson JB, Boulvain M. Risk factors for pelvic organ prolapse repair after hysterectomy. Obstet Gynecol 2007; 110:625.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mant J, Painter R, Vessey M. Epidemiology of genital prolapse: observations from the Oxford Family Planning Association Study. Br J Obstet Gynaecol 1997; 104:579.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blandon RE, Bharucha AE, Melton LJ 3rd, et al. Incidence of pelvic floor repair after hysterectomy: A population-based cohort study. Am J Obstet Gynecol 2007; 197:664.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clark AL, Gregory T, Smith VJ, Edwards R. Epidemiologic evaluation of reoperation for surgically treated pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol 2003; 189:1261.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dallas K, Elliott CS, Syan R, et al. Association Between Concomitant Hysterectomy and Repeat Surgery for Pelvic Organ Prolapse Repair in a Cohort of Nearly 100,000 Women. Obstet Gynecol 2018; 132:1328.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vermeulen CKM, Veen J, Adang C, et al. Pelvic organ prolapse after laparoscopic hysterectomy compared with vaginal hysterectomy: the POP-UP study. Int Urogynecol J 2021; 32:841.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Forsgren C, Lundholm C, Johansson AL, et al. Hysterectomy for benign indications and risk of pelvic organ fistula disease. Obstet Gynecol 2009; 114:594.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hessami K, Welch J, Frost A, et al. Perioperative opioid dispensing and persistent use after benign hysterectomy: a systematic review and meta-analysis. Am J Obstet Gynecol 2023; 229:23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matteson KA, Schimpf MO, Jeppson PC, et al. Prescription Opioid Use for Acute Pain and Persistent Opioid Use After Gynecologic Surgery: A Systematic Review. Obstet Gynecol 2023; 141:681.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 134395 Version 11.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14711749" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : The eVALuate study: two parallel randomised trials, one comparing laparoscopic with abdominal hysterectomy, the other comparing laparoscopic with vaginal hysterectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25042204" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Influences of different hysterectomy techniques on patients' postoperative sexual function and quality of life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10711536" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Effectiveness of hysterectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11120508" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Patient satisfaction with results of hysterectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14525872" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Hysterectomy and sexual wellbeing: prospective observational study of vaginal hysterectomy, subtotal abdominal hysterectomy, and total abdominal hysterectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10580459" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Hysterectomy and sexual functioning.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15820815" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Perimenopausal androgen decline after oophorectomy does not influence sexuality or psychological well-being.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8134066" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : The Maine Women's Health Study: I. Outcomes of hysterectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25433152" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Sexual function after hysterectomy and myomectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25218547" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Quality of life and pelvic floor dysfunction symptoms after hysterectomy with or without pelvic organ prolapse.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10836201" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : The psychological outcome of hysterectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9689206" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Hysterectomy, ovarian failure, and depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10808032" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Sexuality after hysterectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13477786" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Patterns of emotional recovery from hysterectomy; first in a series of reports.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16522402" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : A prospective study of 3 years of outcomes after hysterectomy with and without oophorectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29518640" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : The prevalence of occult endometrial cancer in women undergoing hysterectomy for benign indications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28254678" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Incidence of Occult Uterine Malignancy Following Vaginal Hysterectomy With Morcellation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29528920" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Occult Gynecologic Cancer in Women Undergoing Hysterectomy or Myomectomy for Benign Indications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32604198" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Occult Uterine Malignancy at the Time of Surgery for Pelvic Organ Prolapse: A Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32681994" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Occult Uterine Malignancy at the Time of Sacrocolpopexy in the Context of the Safety Communication on Power Morcellation by the FDA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24211399" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Prevalence of occult gynecologic malignancy at the time of risk reducing and nonprophylactic surgery in patients with Lynch syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29484698" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Intra-operative evaluation of prophylactic hysterectomy and salpingo-oophorectomy specimens in hereditary gynaecological cancer syndromes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14747185" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : A randomized controlled trial of hysterectomy or levonorgestrel-releasing intrauterine system in the treatment of menorrhagia-effect on FSH levels and menopausal symptoms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15957999" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : The association of hysterectomy and menopause: a prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11854933" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Effect of hysterectomy on conserved ovarian function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22067716" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Effect of hysterectomy with ovarian preservation on ovarian function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27054925" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Association of Ovary-Sparing Hysterectomy With Ovarian Reserve.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27540878" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : DETERIORARON OF OVARIAN FUNCTION AFTER TOTAL ABDOMINAL HYSTERECTOMY WITH PRESERVARON OF OVARIES.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21186237" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Hysterectomy and risk of cardiovascular disease: a population-based cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23587399" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Hysterectomy in young women associates with higher risk of stroke: a nationwide cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24253486" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Long-term overall and disease-specific mortality associated with benign gynecologic surgery performed at different ages.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29286988" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34524503" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Impact of hysterectomy on cardiovascular disease and different subtypes: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37307002" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Association of Early Hysterectomy With Risk of Cardiovascular Disease in Korean Women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37192828" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : The association of hysterectomy with or without ovarian conservation with subclinical atherosclerosis progression in healthy postmenopausal women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30768935" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Increased risk of osteoporosis with hysterectomy: A longitudinal follow-up study using a national sample cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/38085540" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Osteoporosis and Fracture Risk Following Benign Hysterectomy Among Female Patients in Korea.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34880044" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Association of bilateral salpingo-oophorectomy with all cause and cause specific mortality: population based cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19035986" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Morbidity outcomes of 78,577 hysterectomies for benign reasons over 23 years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26551173" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Urinary Tract Injury at Benign Gynecologic Surgery and the Role of Cystoscopy: A Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24165027" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Ten years of progress--improved hysterectomy outcomes in Finland 1996-2006: a longitudinal observation study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32145133" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Complications after benign hysterectomy, according to procedure: a population-based prospective cohort study from the Danish hysterectomy database, 2004-2015.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15625150" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Disability and litigation from urinary tract injuries at benign gynecologic surgery in Canada.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11911100" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : The contribution of hysterectomy to the occurrence of urge and stress urinary incontinence symptoms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10950229" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Hysterectomy and urinary incontinence: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17964350" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Hysterectomy and risk of stress-urinary-incontinence surgery: nationwide cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37116821" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Increased risk of stress urinary incontinence surgery after hysterectomy for benign indication-a population-based cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24964761" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Hysterectomy and urinary incontinence in postmenopausal women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27593942" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Factors influencing the incidence and remission of urinary incontinence after hysterectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28633096" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Hysterectomy is not associated with de-novo urinary incontinence: A ten-year cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18355787" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Pelvic organ prolapse surgery following hysterectomy on benign indications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19936593" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : An estimation of the frequency of surgery for posthysterectomy vault prolapse.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17766624" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : ACOG Practice Bulletin No. 85: Pelvic organ prolapse.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24769448" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : AAGL practice report: Practice Guidelines on the Prevention of Apical Prolapse at the Time of Benign Hysterectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9083302" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12066091" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15728164" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Effects of estrogen with and without progestin on urinary incontinence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17766610" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Risk factors for pelvic organ prolapse repair after hysterectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9166201" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Epidemiology of genital prolapse: observations from the Oxford Family Planning Association Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18060973" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Incidence of pelvic floor repair after hysterectomy: A population-based cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14634551" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Epidemiologic evaluation of reoperation for surgically treated pelvic organ prolapse and urinary incontinence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30334856" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Association Between Concomitant Hysterectomy and Repeat Surgery for Pelvic Organ Prolapse Repair in a Cohort of Nearly 100,000 Women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33170314" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Pelvic organ prolapse after laparoscopic hysterectomy compared with vaginal hysterectomy: the POP-UP study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19701040" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Hysterectomy for benign indications and risk of pelvic organ fistula disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36539027" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Perioperative opioid dispensing and persistent use after benign hysterectomy: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36897135" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Prescription Opioid Use for Acute Pain and Persistent Opioid Use After Gynecologic Surgery: A Systematic Review.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
